DB18597InvestigationalProtein Based Therapies
Timolumab is a recombinant, fully-human, IgG4 immunoglobulin with antigen-binding specificity for human vascular adhesion protein-1 (VAP-1).
- Mechanism
- Curator reviewed
Pharmacologically active on Amine oxidase [copper-containing] 3
- Also known as
- recombinant, fully-human, IgG4 immunoglobulin with antigen-binding specificity for human vascular adhesion protein-1 (VAP-1)
- Code names
- BTT-1023
Resolves to
Compound
Targets
What you can answer from here — as of July 20, 2026
Which drugs share a target with Timolumab, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account